| CAS No. | 1239-29-8 |
| Molecular Formula | C20H30N2O2 |
| Molecular Weight | 330.46 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
CATO manufactures 1239-29-8 2W07HSP5PX Furazabol Furazabol [INN:JAN] 5-alpha-Androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol, 17-methyl- 17-Methyl-5alpha-androstano(2,3-c)furazan-17beta-ol 17-Methyl-5alpha-androstano(2,3-c)(1,2,5)oxadiazol-17beta-ol Androfurazanol DH 245 EINECS 214-983-0 Frazalon Furazabolo [DCIT] Furazabolum [INN-Latin] 17-beta-Hydroxy-17-alpha-methyl-5-alpha-androstano(2,3-c)furazan 17-Methyl-5-alpha-androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol Miotolon Myotolon Furazabolo Furazabolum UNII-2W07HSP5PX Qu Zhi Shu DEA No. 4000 17alpha-Methyl-17beta-hydroxyandrostano(2,3-c)-furazan under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
1239-29-8 2W07HSP5PX Furazabol Furazabol [INN:JAN] 5-alpha-Androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol, 17-methyl- 17-Methyl-5alpha-androstano(2,3-c)furazan-17beta-ol 17-Methyl-5alpha-androstano(2,3-c)(1,2,5)oxadiazol-17beta-ol Androfurazanol DH 245 EINECS 214-983-0 Frazalon Furazabolo [DCIT] Furazabolum [INN-Latin] 17-beta-Hydroxy-17-alpha-methyl-5-alpha-androstano(2,3-c)furazan 17-Methyl-5-alpha-androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol Miotolon Myotolon Furazabolo Furazabolum UNII-2W07HSP5PX Qu Zhi Shu DEA No. 4000 17alpha-Methyl-17beta-hydroxyandrostano(2,3-c)-furazan (CAS 1239-29-8), molecular formula C20H30N2O2 and molecular weight 330.46 g/mol, is a CATO reference standard with documented purity and traceability.
The molecular framework of 1239-29-8 2W07HSP5PX Furazabol Furazabol [INN:JAN] 5-alpha-Androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol, 17-methyl- 17-Methyl-5alpha-androstano(2,3-c)furazan-17beta-ol 17-Methyl-5alpha-androstano(2,3-c)(1,2,5)oxadiazol-17beta-ol Androfurazanol DH 245 EINECS 214-983-0 Frazalon Furazabolo [DCIT] Furazabolum [INN-Latin] 17-beta-Hydroxy-17-alpha-methyl-5-alpha-androstano(2,3-c)furazan 17-Methyl-5-alpha-androstano(2,3-c)(1,2,5)oxadiazol-17-beta-ol Miotolon Myotolon Furazabolo Furazabolum UNII-2W07HSP5PX Qu Zhi Shu DEA No. 4000 17alpha-Methyl-17beta-hydroxyandrostano(2,3-c)-furazan (C20H30N2O2) is characterized by a steroid core, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
| Molecular Formula | C20H30N2O2 |
| Molecular Weight | 330.46 g/mol |
| Appearance | Off-white to pale yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 7.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1957 |
| Nitrogen Atoms | 2 |